News / Africa

    Ebola Vaccine Trials Underway in Mali

    FILE - Dr. Felicity Hartnell, who is a clinical research fellow at Oxford University, holds a vial of an experimental vaccine against Ebola, in Oxford, England, Sept. 17, 2014.
    FILE - Dr. Felicity Hartnell, who is a clinical research fellow at Oxford University, holds a vial of an experimental vaccine against Ebola, in Oxford, England, Sept. 17, 2014.
    Katarina HoijeJessica Berman

    A clinical trial of a promising Ebola vaccine has gotten underway in the west African country of Mali, which borders Guinea, the epicenter of the deadly viral epidemic that now has killed 4,000 people.

    This phase of testing of the experimental vaccine against Ebola began this week in Mali when it was given to three health workers who volunteered. The health workers would be the first to fight the disease if it broke out in Bamako.

    Health workers are on the frontline and run the highest risk of being infected, says the director of the Mali center for vaccine development, Dr. Samba Sow.

    The trials are taking place to determine if the potential vaccine is safe and effective, explained Sow.

    Mali has no Ebola cases but it borders Guinea, where the outbreak began.

    So far the researchers haven’t seen any significant ill effects from the vaccine, including Sow, who was the first to be injected.

    "Since I’m the one responsible for the study, it makes sense I’m the first one to volunteer," said Sow.

    Health workers

    The researchers will test blood samples of the volunteers to make sure there is an antibody response, the signal that the vaccine may teach the immune system to recognize the virus and fight it off. Until it is used in health workers actually treating people with Ebola, however, there will be no real proof that it works.

    The trials are proceeding with unprecedented speed and the co-operation of a large number of international organizations and governments, in the hope of having something available that is at least partially protective before the end of the year.

    "I have never seen such a rapid response in developing a vaccine against any disease before," said Sow.

    Trials began in the U.S. and at Oxford University a couple of weeks ago. In Mali, four health workers have been vaccinated so far and an additional 37 will receive the vaccine in the coming weeks.

    The researchers are in the process of “fast tracking” the vaccine to protect health workers, the group that have been hit the hardest since the Ebola outbreak started in late March this year.

    Mali is the first country in Africa where the vaccine is being tested. In a couple weeks the vaccine will also be given to health workers in Ghana.

    Vaccine development

    The vaccine, developed by researchers at the U.S. National Institutes of Health and British drug manufacturer GlaxoSmithKline, was 100 percent effective in protecting monkeys against lethal exposure to Ebola in pre-clinical trials.

    The vaccine stimulates the immune system using a non-infectious Ebola protein carried by a harmless cold virus, according to vaccine researcher Myron Levine, director of the Center for Vaccine Development at the University of Maryland. He is helping conduct the clinical trials in Mali.

    “I’ve been doing vaccine development for 44 years. Hands on, I have never seen anything move so quickly,” said Levine.

    Levine said Mali has good border security, but Ebola is continuing to spread unchecked in Guinea, Liberia and Sierra Leone.

    Like the smallpox vaccine, the one against Ebola could potentially prevent full-blown disease in those exposed to the deadly virus, including health care workers.

    Levine said regulatory approval could quickly follow successful clinical trials.

    “Everybody wants to see the licensure of Ebola vaccine -- trying to get license as quickly as possible as long as the data are there to know that it’s safe, immunogenic and protective,” he said.

    Rapid response

    GlaxoSmithKline is manufacturing 10,000 doses of the vaccine, which Levine said could be administered as soon as the drug gets the nod from regulators in the United States and Europe. He said because of the limited supply, distribution of the vaccine will be targeted initially.

    “When it’s recognized [all the data are in] at least, we can could come in and try to vaccinate family contacts and vaccinate the population around where cases are occurring,” said Levine.

    In addition to Mali, trials of the experimental vaccine have also been carried out in Britain.  

    Levine says two more people in Mali received the vaccine Friday. Another 15 will be vaccinated after that, if all goes as planned.

     


     

     

    You May Like

    Russian-speaking Muslim Exiles Fear Possible Russia-Turkey Thaw

    Exiled from Russia as Islamic radicals and extremists, thousands found asylum in Turkey

    US Presidential Election Ends at Conventions for Territorial Citizens

    Citizens of US territories like Guam or Puerto Rico enjoy participation in US political process but are denied right to vote for president

    UN Syria Envoy: 'Devil Is in the Details' of Russian Aleppo Proposal

    UN uncertain about the possible humanitarian impact of Russian proposal to establish escape corridors in Aleppo

    This forum has been closed.
    Comment Sorting
    Comments
         
    by: East Africa
    October 14, 2014 1:33 PM
    We East Africans don't care for what's going on there. Why you guys eating wild animals

    by: prince odabah from: Liberia
    October 13, 2014 4:08 PM
    It's the good news that I ever heard since the outbreak of ebola in west Africa ,but time is runing out and people are dying so double up your effort.

    by: Craig from: Berkeley CA
    October 12, 2014 12:54 PM
    Why is this being test in Mali where there are no cases and not Liberia where it could sooner be determined to be effective or not? Time is of the essence.

    Missing information is how long teh vaccine takes to become effective. Days? Months? Huge difference.

    If it is really effective 10,000 doses is woefully insufficient. How much investment would be required to make ten million?

    by: Cedric Lucas from: Cape Town South Africa
    October 12, 2014 9:10 AM
    Light at the end of the tunnel!

    by: John
    October 12, 2014 6:05 AM
    I admire Sow's decision to be the first one to volunteer. I hope the vaccine proves to be a success.

    by: ANOGHENA from: Nigeria
    October 10, 2014 7:40 PM
    Good news

    By the Numbers

    Featured Videos

    Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
    Uganda Unveils its First Solar-powered Busi
    X
    July 28, 2016 4:16 AM
    A solar-powered bus described by its Ugandan makers as the first in Africa has made its public debut. Kiira Motors' electric bus, Kayoola, displayed recently at a stadium in Uganda's capital. From Kampala, Maurice Magorane filed this report narrated by Salem Solomon.
    Video

    Video Uganda Unveils its First Solar-powered Bus

    A solar-powered bus described by its Ugandan makers as the first in Africa has made its public debut. Kiira Motors' electric bus, Kayoola, displayed recently at a stadium in Uganda's capital. From Kampala, Maurice Magorane filed this report narrated by Salem Solomon.
    Video

    Video Silicon Valley: More Than A Place, It's a Culture

    Silicon Valley is a technology powerhouse and a place that companies such as Google, Facebook and Apple call home. It is a region in northern California that stretches from San Francisco to San Jose. But, more than that, it's known for its startup culture. VOA's Elizabeth Lee went inside one company to find out what it's like to work in a startup.
    Video

    Video Immigrant Delegate Marvels at Democratic Process

    It’s been a bitter and divisive election season – but first time Indian-American delegate Dr. Shashi Gupta headed to the Democratic National Convention with a sense of hope. VOA’s Katherine Gypson followed this immigrant with the love of U.S. politics all the way to Philadelphia.
    Video

    Video Philadelphia Uses DNC Spotlight to Profile Historic Role in Founding of United States

    The slogan of the Democratic National Convention now underway in Philadelphia is “Let’s Make History Again” which recognizes the role the city played in the foundation of the United States in the 18th century. As VOA’s Kane Farabaugh reports, local institutions are opening their doors in an effort to capitalize on the convention spotlight to draw visitors, and to offer more than just a history lesson.
    Video

    Video A Life of Fighting Back: Hillary Clinton Shatters Glass Ceiling

    Hillary Clinton made history Thursday, overcoming personal and political setbacks to become the first woman to win the presidential nomination of a major U.S. political party. If she wins in November, she will go from “first lady” to U.S. Senator from New York, to Secretary of State, to “Madam President.” Polls show Clinton is both beloved and despised. White House Correspondent Cindy Saine takes a look at the life of the woman both supporters and detractors agree is a fighter for the ages.
    Video

    Video Dutch Entrepreneurs Turn Rainwater Into Beer

    June has been recorded as one of the wettest months in more than a century in many parts of Europe. To a group of entrepreneurs in Amsterdam the rain came as a blessing, as they used the extra water to brew beer. Serginho Roosblad has more to the story.
    Video

    Video First Time Delegate’s First Day Frustrations

    With thousands of people filling the streets of Philadelphia, Pennsylvania for the 2016 Democratic National Convention, VOA’s Kane Farabaugh narrowed in on one delegate as she made her first trip to a national party convention. It was a day that was anything but routine for this United States military veteran.
    Video

    Video Commerce Thrives on US-Mexico Border

    At the Democratic Convention in Philadelphia this week, the party’s presumptive presidential nominee, Hillary Clinton, is expected to attack proposals made by her opponent, Republican presidential nominee Donald Trump, to build a wall along the U.S.-Mexico border. Last Friday, President Barack Obama hosted his Mexican counterpart, President Enrique Peña Nieto, to underscore the good relations between the two countries. VOA’s Greg Flakus reports from Tucson.
    Video

    Video Film Helps Save Ethiopian Children Thought to be Cursed

    'Omo Child' looks at effort of African man to stop killings of ‘mingi’ children
    Video

    Video London’s Financial Crown at Risk as Rivals Eye Brexit Opportunities

    By most measures, London rivals New York as the only true global financial center. But Britain’s vote to leave the European Union – so-called ‘Brexit’ – means the city could lose its right to sell services tariff-free across the bloc, risking its position as Europe’s financial headquarters. Already some banks have said they may shift operations to the mainland. Henry Ridgwell reports from London.
    Video

    Video Recycling Lifeline for Lebanon’s Last Glassblowers

    In a small Lebanese coastal town, one family is preserving a craft that stretches back millennia. The art of glass blowing was developed by Phoenicians in the region, and the Khalifehs say they are the only ones keeping the skill alive in Lebanon. But despite teaming up with an eco-entrepreneur and receiving an unexpected boost from the country’s recent trash crisis the future remains uncertain. John Owens reports from Sarafand.
    Video

    Video Migrants Continue to Risk Lives Crossing US Border from Mexico

    In his speech Thursday before the Republican National Convention, the party’s presidential candidate, Donald Trump, reiterated his proposal to build a wall along the U.S.-Mexico border if elected. Polls show a large percentage of Americans support better control of the nation's southwestern border, but as VOA’s Greg Flakus reports from the border town of Nogales in the Mexican state of Sonora, the situation faced by people trying to cross the border is already daunting.

    Special Report

    Adrift The Invisible African Diaspora